Blood Drug Testing

Home > Drug Test Kits Information > Drug Test Kits News

Drug Test Kits News

  • BioTime Receives $335,900 SBIR Grant Friday, July 15, 2011 @ 7:56AMBioTime, Inc. (NYSE Amex:BTX) today announced it has been awarded a 10-month, $335,900 Small Business Innovation Research (SBIR) grant from the National ...
  • Molecular Detection Gets USPTO OK for MRSA/MSSA MDx Patent Thursday, July 14, 2011 @ 3:44PMMolecular Detection filed the patent application, No. 12/106,137 entitled "Methods, Compositions and Kits for Detection and Analysis of Antibiotic Resistant Bacteria," in March 2009. The company said that the patent is expected to issue sometime in the next few months.
  • Seattle signs Schmid to extension Thursday, July 14, 2011 @ 2:43PMThe marketing and advertising group Extra Credit Projects designed a simple ... The Transportation Security Administration plans to test a program that would ...
  • A-Rod placed on DL Thursday, July 14, 2011 @ 2:28PMThe marketing and advertising group Extra Credit Project designed a simple ... The Transportation Security Administration plans to test a program that would ...
  • Neogen Corporation Announces Year-End Results Conference Call Thursday, July 14, 2011 @ 6:45AMNeogen Corporation announces the following Webcast:
  • Astra Biotech to Debut Cystic Fibrosis Array Test in H2 Wednesday, July 13, 2011 @ 12:44PMAstra Biotech will later this year launch a microarray-based test for the detection of 25 of the most common mutations causing cystic fibrosis in pan-European populations, the firm said this week.
  • Omega Diagnostics puts its growth strategy to the test Wednesday, July 13, 2011 @ 9:41AMOmega Diagnostics puts its growth strategy to the test
  • Consumer Genetic Testing May Not Boost Users' Anxiety Monday, July 11, 2011 @ 1:48PMWEDNESDAY, Jan. 12 (HealthDay News) -- People who have direct-to-consumer genetic testing don't experience any short-term increase in anxiety after receiving the results, whether they are positive or negative, researchers report.
  • Simple measures 'could improve malaria diagnostic kits' Monday, July 11, 2011 @ 10:59AMRapid diagnostic tests (RDTs) for malaria could be greatly improved by a few simple measures, say researchers.
  • Health Highlights: Dec. 1, 2010 Monday, July 11, 2011 @ 7:15AMHere are some of the latest health and medical news developments, compiled by the editors of HealthDay:
  • Molecular Diagnostics in Infectious Disease Testing Monday, July 11, 2011 @ 3:08AMReportlinker.com announces that a new market research report is available in its catalogue:
  • VICAM Introduces Vertu Lateral Flow Reader for Onsite and Laboratory Mycotoxin Detection Thursday, July 7, 2011 @ 7:30AMThe Waters Corporation today announced VICAM®, a Waters® Business, launched Vertuâ¢, a digital lateral flow reader for fast, easy, mycotoxin quantitation. The Vertu reader provides more accessible mycotoxin testing to food and agriculture producers worldwide who rely on early detection to protect humans and animals from potentially lethal effects of contamination.
  • Latest Draft of Hatch IVD Bill Contains New Regulatory Proposals; Pricing Reforms under Discussion Wednesday, July 6, 2011 @ 4:14PMThe latest version of a draft bill on the regulation of in vitro diagnostic products includes new provisions and clarifications that attempt to address the complex ecosystem in which molecular diagnostics are developed, marketed, and used.
  • Camel's milk is believer's cause Tuesday, July 5, 2011 @ 10:03PMHow far would you go for something you believed in? Empty your savings account? Sell your furniture? Cut back on your day job to devote time to it? Millie Hinkle, a natural medicine practitioner from Pittsboro, did all of the above.
  • Getting you to drink camel's milk is this true believer's cause Tuesday, July 5, 2011 @ 4:39PMHow far would you go for something you believed in?
  • Omega Diagnostics Gp - Final Results Monday, July 4, 2011 @ 1:13AMOmega Diagnostics Gp - Final Results
  • Tusk Editor's Note: July 1, 2011 Friday, July 1, 2011 @ 11:46PMIt's a tradition in my family to disparage one musical form or another with reductive, onomatopoeic criticisms. My maternal grandfather, the prototypical barber with a million jokes, shamed all classical music as “that rump-tiddy, rump-tiddy, rump-tiddy-rump.” My own dad distilled rock ‘n' roll into “that darn thump thump thump.”
  • A Good Start to the Summer: Morrison School Board June Meeting Tuesday, June 28, 2011 @ 5:05PMBoard members of the Morrison School district met in Superintendent Girard’s office on Tuesday, June 21, 2011.
  • A case of shattered trust Sunday, June 26, 2011 @ 12:11AMFor a decade, the U.S. Food and Drug Administration was aware of problems at a Wisconsin manufacturer of medical products, including alcohol wipes, but took no enforcement action. Now those wipes have been linked to a deadly bacterium.
  • Rheonix, Mayo Clinic Ink Pact to Evaluate Warfarin-Sensitivity Test Thursday, June 23, 2011 @ 9:44AMEarly-stage clinical diagnostics company Rheonix and the Mayo Clinic said this week that they are collaborating to evaluate the performance of a genotyping test for warfarin sensitivity in clinical and research settings.
  • Residents push for public safety in Piñon Thursday, June 23, 2011 @ 7:27AMVanessa Gene spoke urgently about the need for better facilities to fight crime in her hometown of Piñon, Ariz., statistically one of the most crime-ridden spots in the Navajo Nation.
  • HIV/AIDS Testing Offered Free of Charge by Walgreens Thursday, June 23, 2011 @ 3:23AM  Select Walgreens throughout the country will offer free HIV/AIDS testing and resources, according to an article at DrugStoreNews.com....
  • Exalenz Bioscience Aligns U.S. Product Offering around Innovative 10-Minute Breath Test for H. pylori Wednesday, June 22, 2011 @ 9:13AMWILMINGTON, Del.--(BUSINESS WIRE)--Exalenz Bioscience, a provider of breath testing equipment for diagnosing digestive conditions, will focus on the BreathID® Urea Breath Test System and companion cannula-based testing kit in the U.S.
  • LTO employees dared to take drug test also Monday, June 20, 2011 @ 11:16AMWhile the president of the Cebu South Mini-Bus Operators Association lauded the random drug testing among public utility vehicle drivers conducted by the Land Transportation Office, he also challenged LTO employees to take the same test.
  • Neogen Acquires VeroMara from GlycoMar Ltd. Monday, June 20, 2011 @ 11:08AMLANSING, Mich., June 20, 2011 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that it has acquired the assets of the VeroMara seafood testing laboratory from its parent company, GlycoMar Ltd. Based in Oban, Scotland, VeroMara offers testing services to the shellfish and salmon aquaculture industries. VeroMara's services include testing for shellfish toxins, general foodborne ...
  • Recycling water in space Monday, June 20, 2011 @ 9:02AMDuring the last space shuttle flight, astronauts will test a new method for recycling 'used' water. Water is essential for life, and having access to water beyond Earth will be a major obstacle for future space explorers.
  • Muscovites grab 3,000 drug test kits in two hours Monday, June 20, 2011 @ 6:09AMVolunteers handed out 3,000 free drug test kits shortly after the opening of the "Start with Yourself” anti-drug event in Moscow on June 18. The kits detect traces of the most common drugs in the human body, such as morphine, marijuana, amphetamines, methamphetamines and cocaine. Activists also handed out booklets with the addresses of drugs advice and treatment centers.
  • Reportlinker Adds Global Microbiology Testing Market: US, Europe, Japan--Emerging Opportunities and Business Expansion ... Monday, June 20, 2011 @ 6:09AMReportlinker.com announces that a new market research report is available in its catalogue:
  • Government of Canada Supports Innovation in Kingston Friday, June 17, 2011 @ 1:53PMKINGSTON, ONTARIO--(Marketwire - June 17, 2011) - Businesses in manufacturing, engineering and life sciences will have an opportunity to bring new products to market, expand and create new jobs thanks to a new partnership with Queen's University. Member of Parliament Gord Brown, on behalf of the Honourable Gary Goodyear, Minister of State for the Federal Economic Development Agency for Southern ...
  • Press Release Thursday, June 16, 2011 @ 2:03AMSurModics Inc. Posted on:16 Jun 11 SurModics, Inc. (Nasdaq: SRDX), a leading provider of drug delivery and surface modification technologies to the healthcare industry, responded to Johnson & Johnson’s announcement earlier today that Cordis Corporation, a J&J company, will stop the manufacture of CYPHER® and CYPHER SELECT® Plus Sirolimus-Eluting Coronary Stents by the end of 2011.
  • SurModics Comments on Johnson & Johnson Announcement Wednesday, June 15, 2011 @ 2:41PMSurModics, Inc. (Nasdaq: SRDX), a leading provider of drug delivery and surface modification technologies ...
  • ´In Vitro Diagnostic Revenues Will Reach $59.2bn in 2015´ Says visiongain Report Wednesday, June 15, 2011 @ 3:22AMLONDON, June 15, 2011 /PRNewswire/ - http://www.visiongain.com/Report/629/In-Vitro-Diagnostics-World-Market-Outlook-2011-2021 A new report by London-based business information company visiongain predicts that world in vitro diagnostic revenues …
  • MILLVILLE AFTERNOON POLICE BEAT Includes pregnancy test used at Rite Aid Wednesday, June 15, 2011 @ 2:13AMA Rite Aid manager told police Monday two young women used one of the store’s pregnancy test kits in the store’s restroom. The women ran out of the store once staff discovered what they were doing.
  • Press Release Friday, June 10, 2011 @ 12:02PMMeridian Bioscience Inc. Posted on:10 Jun 11 Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that its tests detect the deadly toxins produced by the recent outbreak strain E. coli O104:H4.
  • LGL to host third annual pharmacogenetic conference on 8-9th November 2011 Friday, June 10, 2011 @ 1:05AMLondon Genetics Limited, an expert in the use of pharmacogenetics in clinical drug discovery and development, is pleased to announce that its third annual pharmacogenetic conference will feature top-level presentations from players in all parts of the healthcare chain.
  • Francis Galton: Polymath, eugenicist, comedian Wednesday, June 8, 2011 @ 10:54AMA hundred years after the death of Francis Galton, New Scientist discovers a funny side to the eugenicist
  • LeBron James in spotlight off-court, too. Is he selling caffeine to kids? Tuesday, June 7, 2011 @ 6:24PMAs basketball star LeBron James tries to take a step closer to the championship that has so far eluded him in Game 4 of the NBA Finals Tuesday, his off-the-court activities are drawing the ire of a number of pediatricians nationwide.
  • E. coli O104 Outbreak Highlights Need for Rapid, Accurate Testing Options Tuesday, June 7, 2011 @ 11:41AMThe recent E. coli outbreak making headlines in Europe and the United States has been identified as a rare and unique strain, E. coli ...
  • Supreme Court Rules for Roche Over Stanford in Patent Case Monday, June 6, 2011 @ 5:32PMIn a 7-to-2 decision, the court says a contract gives a drug company, Roche Molecular, the rights to a widely used H.I.V. test developed by a doctor.
  • Neogen’s BetaStar Plus Dairy Antibiotic Test Approved by FDA Monday, June 6, 2011 @ 2:13PMThe Lansing biotech products developer Neogen Corp. (Nasdaq: NEOG) said Monday it had received approval from the United States Food and Drug Administration and the National Conference on Interstate Milk Shipments for its BetaStar Plus assay, developed for use in the United States to detect dairy antibiotic residues, including ceftiofur, in milk.
  • Complete Genomics, Affymetrix Make Their Pitch to Investors at Jefferies Conference Monday, June 6, 2011 @ 1:51PMNEW YORK (GenomeWeb News) – The Jefferies 2011 Healthcare Conference kicked off today in New York City. Below are highlights from companies in the life science tools space that presented earlier in the day.
  • Neogen's BetaStar® Plus Dairy Antibiotic Test Approved by FDA/NCIMS Monday, June 6, 2011 @ 9:53AMLANSING, Mich., June 6, 2011 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) has received approval from the FDA and National Conference on Interstate Milk Shipments (NCIMS) for its quick and easy BetaStar® Plus assay, developed for use in the United States to detect dairy antibiotic residues, including ceftiofur, in milk. This approval allows milk producers and processors in the U.S. to use ...
  • Companion Diagnostics: Technologies and Global Markets Monday, June 6, 2011 @ 8:00AMReportlinker.com announces that a new market research report is available in its catalogue:
  • High-Performance Separation And ESI Module From Beckman Coulter Expands The Reach Of Mass Spectrometry Monday, June 6, 2011 @ 2:15AMThe CESI 8000 High-Performance Separation-ESI Module with OptiMS Technology from Beckman Coulter, Inc. consists of the first commercial CESI sprayer combined with new capillary electrophoresis instrumentation specifically designed for mass spectrometry (MS).
  • Avacta Group PLC - Avacta secures second Optim sale in US Tuesday, May 31, 2011 @ 1:24AMAvacta Group PLC - Avacta secures second Optim sale in US
  • SQI Diagnostics reports net loss of $1,874,000 for second quarter 2011 Monday, May 30, 2011 @ 11:13AMSQI Diagnostics Inc., a life sciences company that develops and commercializes proprietary multiplexing technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the second quarter ended March 31, 2011.
  • Transgenomic Licenses Technology to Predict EGFR Inhibitor Response Thursday, May 26, 2011 @ 2:06PMNEW YORK (GenomeWeb News) – Transgenomic today announced it has acquired an exclusive worldwide license to biomarkers for predicting patient response to EGFR inhibitors.
  • D&W Fine Pack Launches REVIVE™ Sustainable Product Line Made from 100 Percent Sugarcane Fiber Thursday, May 26, 2011 @ 2:00PMLine Features Broad Custom Options, Compatibility with Existing Products
  • Merck's VICTRELIS receives European CHMP positive opinion for treatment of chronic HCV genotype 1 infection Friday, May 20, 2011 @ 7:42AMMerck, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion under accelerated assessment recommending approval of the investigational medicine VICTRELIS (boceprevir) for the treatment of chronic hepatitis C virus genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients with ...
  • Medivir reports positive results from ASPIRE TMC435 phase 2b study for genotype 1 chronic hepatitis C Friday, May 20, 2011 @ 5:05AMMedivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases, today announced results from the ASPIRE phase 2b study that evaluates the addition of once daily TMC435 to pegylated interferon and ribavirin in patients with genotype 1 chronic hepatitis C whose prior treatment with pegylated-interferon (PegIFN) and ribavirin (RBV) was unsuccessful either ...